KemPharm
KMPH
#8553
Rank
โ‚ฌ0.16 B
Marketcap
4,89ย โ‚ฌ
Share price
-0.34%
Change (1 day)
-7.97%
Change (1 year)

Revenue for KemPharm (KMPH)

Revenue in 2022 (TTM): โ‚ฌ9.92 Million

According to KemPharm's latest financial reports the company's current revenue (TTM ) is โ‚ฌ8.8 Million. In 2021 the company made a revenue of โ‚ฌ25.29 Million an increase over the revenue in the year 2020 that were of โ‚ฌ10.8 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for KemPharm from 2014 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ9.92 M-60.78%
2021 โ‚ฌ25.29 M134.17%
2020 โ‚ฌ10.8 M-5.74%
2019 โ‚ฌ11.46 M
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Theravance Biopharma
TBPH
โ‚ฌ67.66 M 668.09% Cayman Islands
Jazz Pharmaceuticals
JAZZ
โ‚ฌ3.50 B 39,657.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ANI Pharmaceuticals
ANIP
โ‚ฌ0.69 B 7,806.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
โ‚ฌ18.16 M 106.23%๐Ÿ‡บ๐Ÿ‡ธ USA